论文部分内容阅读
目的探讨血必净治疗重症肺炎的临床效果。方法选取2013年1月—2014年2月梧州市中医医院收治的重症肺炎患者60例,随机分为观察组与对照组,各30例。对照组患者均予以常规方法治疗,观察组在对照组基础上加用血必净治疗。观察两组患者临床疗效、白细胞计数恢复正常时间、C反应蛋白恢复正常时间、住院时间及皮肤瘙痒、过敏和出血等不良反应发生情况。结果观察组患者总有效率高于对照组,差异有统计学意义(P<0.05);观察组患者白细胞计数恢复正常时间、C反应蛋白恢复正常时间及住院时间短于对照组,差异有统计学意义(P<0.05);两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论血必净治疗重症肺炎的临床效果显著,可改善患者免疫功能,且不良反应小。
Objective To investigate the clinical effect of Xuebijing in the treatment of severe pneumonia. Methods Sixty patients with severe pneumonia admitted from January 2013 to February 2014 in Wuzhou Chinese Medicine Hospital were randomly divided into observation group and control group, with 30 cases in each group. The control group patients were treated by conventional methods, the observation group in the control group plus Xuebijing treatment. Two groups of patients were observed clinical efficacy, normal white blood cell count recovery, C-reactive protein recovery time, length of hospital stay and itchy skin, allergies and bleeding and other adverse reactions. Results The total effective rate of the observation group was higher than that of the control group (P <0.05). The recovery time of white blood cell count, normal recovery time of C-reactive protein and hospitalization time in the observation group were shorter than those in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion Xuebijing treatment of severe pneumonia clinical effect is significant, can improve immune function, and adverse reactions.